BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Kane Biotech Announces Date of Q3 Earnings 2019 Release

  Kane Biotech Inc.,, a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, announced that they will release third quarter fiscal 2019 earnings on Thursday, November 14 after market close.

  November 6, 2019

   · 

  2 min read
• Business

  Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights

  Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, reported financial results for the third quarter ended September 30, 2019, and provided business highlights.

  November 6, 2019

   · 

  7 min read
• Deals

  Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019

  Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event

  November 6, 2019

   · 

  2 min read
• Deals

  Invacare Reports Results for Third Quarter 2019

  Transformation delivers significant improvement in profitability and free cash flow Full year 2019 and 2020 guidance reaffirmed Reduced convertible debt due in 2021 by $16 million

  November 6, 2019

   · 

  27 min read
• Deals

  CRH Medical Receives TSX Approval for Renewal of Normal Course Issuer Bid - Nov. 6, 2019

  CRH Medical Corporation, announces that it has received approval from the Toronto Stock Exchange of its Notice of Intention to renew its existing Normal Course Issuer Bid.

  November 6, 2019

   · 

  12 min read
• BioMidwest

  Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference

  Baxter International Inc., a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019.

  November 6, 2019

   · 

  1 min read
• Business

  Cellular Biomedicine Group Reports Third Quarter of 2019 Financial Results and Business Highlights

  Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported its financial results and business highlights for the third quarter of 2019.

  November 6, 2019

   · 

  11 min read
• Genetown

  Axcella Achieves Initial Milestones with its Hematology Product Candidate AXA4010

  Non-IND clinical study initiated to assess safety, tolerability and blood physiology; first subjects with sickle cell disease enrolled

  November 6, 2019

   · 

  7 min read
• BioMidwest

  Walgreens Flu Index® Shows New Areas Lead in October Flu Activity Year-Over-Year

  First Monthly Walgreens Flu Index for October 2019 Shows Louisiana and Nevada Leading Texas on the State List for Flu Activity

  November 6, 2019

   · 

  3 min read
• Business

  UroGen Pharma to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

  UroGen Pharma Ltd. announced that it will report third quarter 2019 financial results on Tuesday, November 12, 2019, prior to the open of the market.

  November 6, 2019

   · 

  1 min read